ENTITY

Pdl Biopharma (PDLI US)

14
Analysis
Health CareUnited States
PDL BioPharma Inc. manages a portfolio of patents and royalty assets, consisting primarily of its Queen et al. antibody humanization patents and license agreements with various biotechnology and pharmaceutical companies. The Company is focused on intellectual property asset management and acquiring new income generating assets.
more
Exchange Announcement10 Feb 2023 22:42
Exchange Announcement08 Feb 2022 23:52
Exchange Announcement27 Mar 2021 02:32
Exchange Announcement20 Feb 2021 01:13
Exchange Announcement12 Feb 2021 23:20
x